PROTECT YOUR DNA WITH QUANTUM TECHNOLOGY
Orgo-Life the new way to the future Advertising by AdpathwayA qualitative investigation published in the International Journal of Clinical Pharmacy reveals that hospital pharmacists across China demonstrate strong personal motivation and professional dedication toward conducting pharmacy practice research, yet their day-to-day engagement remains deeply constrained by structural shortages in protected research time, formal methodological competence, and institutional infrastructure. Conducted by investigators from the School of Pharmacy at Nanjing Medical University, the study systematically evaluated how practitioners working within high-tier healthcare institutions perceive and pursue clinical investigation. Although clinical pharmacy services have expanded globally to improve patient outcomes, optimize therapeutic regimens, and address complex multimorbidity, pharmacy practice research within China is still recognized as an emerging discipline that has predominantly relied on small-sample, single-center studies. By examining the firsthand experiences of experienced practitioners across multiple geographic regions, the research team established that while practitioners view practice-based investigation as integral to advancing pharmaceutical care, the translation of professional willingness into sustained investigative output is hindered by substantial capability- and opportunity-related obstacles.
To rigorously capture these dynamics, the study adopted a qualitative descriptive design situated within an interpretivist paradigm, structured according to the Consolidated Criteria for Reporting Qualitative Research guidelines. Theoretical framing was guided by the Capability, Opportunity, Motivation–Behavior model, widely known as the COM-B framework, to identify the multi-level determinants governing research engagement. The investigative team comprised clinical pharmacy postgraduate researchers who brought relevant hospital pharmacy practice experience to the interview design, data gathering, and analytical procedures. Data collection was undertaken between June and August 2025 using one-on-one, semi-structured interviews conducted remotely on Tencent Meeting. Each interview lasted between 30 and 60 minutes and was audio-recorded and transcribed verbatim for in-depth evaluation. Methodological credibility was maintained through deliberate researcher reflexivity, including continuous documentation of methodological decisions and analytical interpretations, alongside iterative reviews of field notes that allowed the research team to explore emergent lines of inquiry while preserving consistency with the central interview guide.
Participant recruitment utilized a combination of purposive and snowball sampling to ensure broad variation across administrative job roles, practice settings, academic qualifications, and geographic regions. To guarantee that contributors possessed extensive professional expertise in clinical service delivery, department management, and operational problem-solving, the researchers established strict eligibility criteria requiring a bachelor degree or higher, a professional title of supervising pharmacist or above, and at least ten years of direct hospital pharmacy experience. A total of 45 eligible practitioners were contacted across China, of whom 21 completed the comprehensive interview process until thematic saturation was achieved. All participating practitioners were affiliated with Grade A tertiary general hospitals, which represent the highest tier of hospital accreditation and encompass large, comprehensive medical centers delivering advanced clinical care, medical education, and clinical research. The cohort encompassed healthcare practitioners operating in fourteen provinces and municipalities spanning all seven major geographical regions of the country, ensuring wide national representation.
The demographic profile of the 21 participants reflected senior, highly experienced practitioners, comprising eight men and 13 women with an overall mean age of 42.2 years and a mean professional hospital experience of 17 years. In terms of professional distribution within Chinese hospital systems, 17 participants, accounting for 81.0 percent of the sample, were clinical pharmacists directly engaged in patient-oriented care duties such as therapeutic drug monitoring, bedside medication review, and clinical consultations. The remaining four participants, representing 19.0 percent, were dispensing pharmacists primarily responsible for core logistical and technical operations, including medication supply management, prescription review, and high-volume pharmaceutical dispensing. Prior to commencement, the formal research protocol received ethical clearance from the Ethics Committee of Donghai County People’s Hospital under approval number 2025-KY-110, dated May 29, 2025, and all participants provided written informed consent. Qualitative coding was conducted independently by two researchers using NVivo 12 software, utilizing data-driven thematic analysis mapped iteratively across the three core COM-B domains.
Within the capability domain of the COM-B model, researchers identified three distinct subthemes centered on practitioners’ conceptual understanding of research, their baseline investigative skills, and their prioritized targets for future development. Participants generally perceived pharmacy practice research as being fundamentally embedded within their everyday clinical activities, viewing the discipline as encompassing clinical pharmacy services, drug administration policy, and institutional medication safety management rather than traditional laboratory bench science. However, a major and pervasive capability constraint was inadequate research competence, specifically limited foundational training in study design, statistical modeling, research methodology, and academic manuscript preparation. Participants reported that early design flaws frequently compromise study validity, cause projects to stall, or result in inconclusive outcomes. Practitioners underscored an urgent necessity to strengthen practical competencies around precision pharmaceutical care, individualized dosing adjustments, and emerging digital systems including artificial intelligence, real-world data analytics, and big-data tools designed to forecast adverse drug events.
Opportunity-related influences revealed critical structural and organizational realities that govern whether hospital pharmacists can successfully conduct scientific investigations alongside their primary clinical obligations. While pharmacists based in prominent academic teaching hospitals within economically developed provinces described supportive institutional research atmospheres featuring academic research groups and structured appraisal incentives, opportunity-related barriers were formidable across the wider sample. Nearly all participants reported that heavy everyday workloads left them with no protected working hours for scientific inquiry, forcing them to conduct research entirely during personal leisure time or through unpaid overtime. Dispensing staff face relentless prescription-filling schedules, whereas clinical pharmacists shoulder extensive administrative paperwork on top of direct clinical duties. Furthermore, physical and financial resource constraints remain acute, characterized by scarce research funding, underdeveloped hospital data infrastructure, and an absence of specialized analytical equipment such as advanced therapeutic drug monitoring hardware, all of which directly inhibit the realization of clinical studies.
The study also documented external opportunity challenges in healthcare delivery, including limited patient awareness and low participant compliance during longitudinal follow-up, which impede prospective data collection and clinical outcome tracking. Conversely, interdisciplinary collaboration emerged as one of the most powerful facilitators within the opportunity domain. Participants repeatedly emphasized that establishing close, functional partnerships with medical doctors and information technology specialists is vital for defining clinically meaningful research questions, navigating complex electronic health records, securing patient data, and translating analytical findings back into direct clinical decision-making. However, pharmacists recognized that fostering such interdisciplinary ties requires them to demonstrate measurable clinical competence and clearly communicate the unique value of clinical pharmacy services to physicians and hospital leadership, demonstrating that organizational opportunity interacts dynamically with practitioner capability rather than functioning as an isolated variable.
In the motivation domain, participants uniformly recognized the transformative value of pharmacy practice research, describing deep intrinsic and extrinsic incentives for professional engagement. Practitioners expressed that investigating clinical questions generates profound personal fulfillment, particularly when research leads directly to resolved patient issues, enhanced medication safety, and the broader institutional recognition of pharmacists as indispensable clinical decision-makers. Personal academic curiosity and the desire to enhance professional competitiveness were widely highlighted as key internal motivators. Extrinsically, institutional career advancement and formal professional title promotions served as powerful catalysts, given that scientific publications and research achievements are formal criteria for career progression in tertiary healthcare institutions. Nevertheless, investigators noted organizational challenges, as pharmacists working in departments with superficial practice scopes restricted entirely to routine dispensing voiced diminished motivation, demonstrating that environments lacking advanced clinical care opportunities stifle investigative interest.
In discussing these observations, the study authors emphasized that pharmacy practice research must be clearly distinguished from routine clinical audits, internal quality improvement initiatives, and service evaluations to establish recognized methodological boundaries and enhance scientific rigor. Drawing on behavioral theory, the authors noted that while practitioner motivation is essential to initiate research, motivation alone is structurally insufficient to ensure long-term engagement when severe capability and opportunity deficits persist. Several participants even acknowledged experiencing reduced motivation once individual title promotion milestones were attained, proving that sustainable research productivity requires robust structural conditions. The authors highlighted that the deep imbalance between excessive daily workloads and research expectations creates a systemic bottleneck. Consequently, building sustainable investigative capacity across Chinese hospitals requires dedicated protected time, institutional seed funding, formalized biostatistical and methodological training, and the active modernization of electronic health record systems to facilitate data retrieval.
The authors outlined important study limitations that contextualize the transferability of their qualitative conclusions. Because all 21 participants were purposively recruited from Grade A tertiary general hospitals and possessed at least a decade of professional experience alongside senior professional titles, their viewpoints reflect the realities of well-resourced environments and senior personnel. Consequently, these findings may not fully represent the unique challenges, training gaps, or distinct professional barriers experienced by early-career practitioners, junior pharmacists, or healthcare staff working in primary care centers, community pharmacies, and industrial pharmaceutical environments. Despite these boundaries, the authors observed that the documented challenges of excessive workload, limited methodological training, and scarce institutional resources closely mirror barriers reported internationally across diverse healthcare jurisdictions. Overcoming these entrenched obstacles will ultimately require health system administrators to cultivate supportive organizational cultures, formalize research training pathways, and institutionalize interdisciplinary collaboration to strengthen evidence-based clinical pharmacy practice.
Subject of Research: Qualitative evaluation of hospital pharmacists' engagement in pharmacy practice research in China using the COM-B framework
Article Title: Hospital pharmacists’ perceptions, needs, barriers, and facilitators of pharmacy practice research in China: a qualitative study
Article References: Zhang, C., Wu, Y., & Li, X. (2026). Hospital pharmacists’ perceptions, needs, barriers, and facilitators of pharmacy practice research in China: a qualitative study. International Journal of Clinical Pharmacy, 48(5), 2117-2127. https://doi.org/10.1007/s11096-026-02197-x
Image Credits: AI Generated
DOI: 10.1007/s11096-026-02197-x
Keywords: pharmacy practice research, hospital pharmacy, clinical pharmacists, dispensing pharmacists, qualitative study, COM-B model, tertiary hospitals, China healthcare, research competence, institutional support, interdisciplinary collaboration, workload constraints, precision medicine, pharmaceutical care, thematic analysis, health services research


1 day ago
17




















English (US) ·
French (CA) ·